Cerebrovascular hemodynamics in fetuses with congenital heart disease

Tingting Man1, Yihua He1, Ying Zhao1

  • 1Department of Ultrasound, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Insights

Congenital heart defects (CHD) in fetuses do not consistently show the "brain sparing effect." Cerebral blood flow (MCA-PI) varies with specific heart defects, unlike the cerebroplacental ratio (CPR).

Area of Science:

  • Fetal Cardiology
  • Neurodevelopmental Outcomes
  • Hemodynamics

Background:

  • The "brain sparing effect," characterized by diminished cerebral vascular resistance, is hypothesized in fetuses with complex congenital heart defects (CHD).
  • This effect's association with neurodevelopmental outcomes and its relation to specific left heart obstructive defects require further investigation.
  • Understanding fetal hemodynamic changes in CHD is crucial for assessment and prognosis.

Purpose of the Study:

  • To determine the impact of various left and right heart obstructive defects on fetal cerebral and placental hemodynamics.
  • To evaluate the utility of these hemodynamic variables for assessing and predicting outcomes in fetuses with CHD.

Main Methods:

  • Reviewed 290 fetal echocardiograms (91 CHD, 199 controls).
  • Categorized CHD fetuses into left-sided obstructive lesions (LSOL), hypoplastic left heart syndrome (HLHS), right-sided obstructive lesions (RSOL), and hypoplastic right heart syndrome (HRHS).
  • Measured middle cerebral artery (MCA-PI) and umbilical artery (UA-PI) pulsatility indices using Doppler, calculated Z scores, and derived the cerebroplacental ratio (CPR).

Main Results:

  • No significant difference in MCA-PI between CHD groups and controls.
  • MCA-PI decreased in aortic stenosis but increased in pulmonary atresia subgroups compared to controls.
  • No significant difference in CPR across any study group or subgroup compared to controls.

Conclusions:

  • MCA-PI variations in CHD are linked to outflow obstruction and hemodynamics, not a generalized "brain sparing effect."
  • Cerebroplacental ratio (CPR) is not a sensitive indicator of CHD's impact on fetal circulation.
  • Specific obstructive lesions influence MCA-PI differently, suggesting tailored prognostic assessments.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
572
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
4.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
388
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
351
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
695